Answers are grounded in this paper and cite their sources.
Low seroconversion rates following HPV infection leave men susceptible to recurrent infections that can progress to HPV-related cancers. This emphasizes the need for HPV vaccination in men to ensure immune protection against new HPV infections and subsequent disease.
No takes yet. Share an insight, caveat, or question.
Giuliano et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: